Erratum: Cytomegalovirus and Glioblastoma: A Review of Evidence for Their Association and Indications for Testing and Treatment (J Neuropathol Exp Neurol (2014) 73 (994-8) DOI: 10.1097/NEN.0000000000000125);Cytomegalovirus and glioblastoma: A review of evidence for their association and indications for testing and treatment

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 11, 2014, Pages 994-998

  Solomon, Isaac H ^a,b   Ramkissoon, Shakti H ^a,b,c   Milner, Danny A ^a,b   Folkerth, Rebecca D ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CMV; Cytomegalovirus; Glioblastoma; Glioma; Valganciclovir

Indexed keywords

CIDOFOVIR; GANCICLOVIR; NUCLEIC ACID; VALGANCICLOVIR; VIRUS PROTEIN; ANTIVIRUS AGENT;

ADJUVANT THERAPY; ANTIBODY BLOOD LEVEL; ANTIGEN RETRIEVAL; ANTIVIRAL THERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; NONHUMAN; OVERALL SURVIVAL; PATHOGENESIS; REVIEW; SYSTEMATIC REVIEW; TUMOR GROWTH; VIRUS DETECTION; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; DRUG EFFECTS; ISOLATION AND PURIFICATION; TREATMENT OUTCOME; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; GANCICLOVIR; GLIOBLASTOMA; HUMANS; TREATMENT OUTCOME;

EID: 84916226618     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000163     Document Type: Erratum

References (43)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109
2. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: A clinical review. JAMA 2013;310:1842-50
3. Sturm D, Bender S, Jones DT, et al. Paediatric and adult glioblastoma: Multiform (epi)genomic culprits emerge. Nat Rev Cancer 2014;14:92-107
4. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;1:702-3
5. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33
6. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;78:1-30
7. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009;15:971-76
8. De Flora S, Bonanni P. The prevention of infection-associated cancers. Carcinogenesis 2011;32:787-95
9. Walker DL, Padgett BL, ZuRhein GM, et al. Human papovavirus (JC): Induction of brain tumors in hamsters. Science 1973;181:674-76
10. Scherneck S, Rudolph M, Geissler E, et al. Isolation of a SV40-like Papovavirus from a human glioblastoma. Int J Cancer 1979;24:523-31
11. Uchida S, Watanabe S, Aizawa T, et al. Induction of papillary ependymomas and insulinomas in the Syrian golden hamster by BK virus, a human papovavirus. Gann 1976;67:857-65
12. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002;62: 3347-50
13. Stragliotto G, Rahbar A, Solberg NW, et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study. Int J Cancer 2013;133:1204-13
14. Boeckh M, Geballe AP. Cytomegalovirus: Pathogen, paradigm, and puzzle. J Clin Invest 2011;121:1673-80
15. Lau SK, Chen YY, Chen WG, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005;18:838-43
16. Sabatier J, Uro-Coste E, Pommepuy I, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 2005;92:747-50
17. Poltermann S, Schlehofer B, Steindorf K, et al. Lack of association of herpesviruses with brain tumors. J Neurovirol 2006;12:90-99
18. Mitchell DA, Xie W, Schmittling R, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 2008;10:10-18
19. Scheurer ME, Bondy ML, Aldape KD, et al. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 2008;116:79-86
20. Lucas KG, Bao L, Bruggeman R, et al. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 2011;103:231-38
21. Bhattacharjee B, Renzette N, Kowalik TF. Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 2012;86:6815-24
22. Fonseca RF, Kawamura MT, Oliveira JA, et al. The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz 2012;107:953-54
23. Dos Santos CJ, Stangherlin LM, Figueiredo EG, Corrêa C, Teixeira MJ, da Silva MC. High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol 2014;86:1953-61
24. Rahbar A, Orrego A, Peredo I, et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 2013;57:36-42
25. Tang KW, Alaei-Mahabadi B, Samuelsson T, et al. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 2013;4:2513
26. Cimino PJ, Zhao G, Wang D, et al. Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. Exp Mol Pathol 2014;96:310-15
27. Ding D, Han S, Wang Z, et al. Does the existence of HCMV components predict poor prognosis in glioma? J Neurooncol 2014;116:515-22
28. Yamashita Y, Ito Y, Isomura H, et al. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol 2014;27:922-29
29. Dziurzynski K, Chang SM, Heimberger AB, et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-oncology 2012;14:246-55
30. Cobbs CS. Cytomegalovirus and brain tumor: Epidemiology, biology and therapeutic aspects. Curr Opin Oncol 2013;25:682-88
31. Soroceanu L, Akhavan A, Cobbs CS. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 2008;455:391-95
32. Straat K, Liu C, Rahbar A, et al. Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 2009;101:488-97
33. Matlaf LA, Harkins LE, Bezrookove V, et al. Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One 2013;8:e68176
34. Price RL, Song J, Bingmer K, et al. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res 2013; 73:3441-50
35. Hollon TC, Price RL, Kwon CH, et al. Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus. Oncoimmunology 2013;2:e25620
36. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: Increasing evidence and open questions. Neoplasia 2009;11:1-9
37. Slinger E, Maussang D, Schreiber A, et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6YSTAT3 axis. Sci Signal 2010;3:ra58
38. Soroceanu L, Matlaf L, Bezrookove V, et al. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res 2011;71:6643-53
39. Krause PR, Bialek SR, Boppana SB, et al. Priorities for CMV vaccine development. Vaccine 2013;32:4-10
40. Soderberg-Naucler C, Rahbar A, Stragliotto G. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 2013;369:985-86
41. Weller M, Soffietti R, Brada M. The legend of cytomegalovirus and glioblastoma lives on. Neuro-oncology 2014;16:166
42. Wick W, Wick A, Platten M. Challenging cytomegalovirus data in glioblastoma. Neuro-oncology 2014;16:165
43. Hadaczek P, Ozawa T, Soroceanu L, et al. Cidofovir: A novel antitumor agent for glioblastoma. Clin Cancer Res 2013;19:6473-83